How we say no: norepinephrine, inferior frontal gyrus, and response inhibition.
Aston-Jones
Gary
G
Department of Neurosciences, Medical University of South Carolina, 173 Ashley Avenue, Charleston, SC 29425, USA. astong@musc.edu
Gold
Joshua I
JI
D000322:Adrenergic Agonists / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D005625:Frontal Lobe / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007266:Inhibition, Psychological; D009638:Norepinephrine / Q000502:physiology*; D011437:Propylamines / Q000494:pharmacology*; D011930:Reaction Time / Q000187:drug effects / Q000502:physiology*
D000322:Adrenergic Agonists; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride; D009638:Norepinephrine